High prevalence of thyroid dysfunction in adult patients with β-thalassemia major submitted to amiodarone treatment

Journal of Endocrinological Investigation

Volumn 22, Issue 1, 1999, Pages 55-63

  Mariotti, Stefano ^a   Loviselli, A ^a   Murenu, S ^a   Sau, F ^a   Valentino, L ^a   Mandas, A ^a   Vacquer, S ^a   Martino, E ^b   Balestrieri, A ^a   Lai, M E ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b UNIVERSITY OF PISA   (Italy)

Author keywords

Amiodarone; Hemosyderosis; Hyperthyroidism; Hypothyroidism; Iodine excess; thalassemia

Indexed keywords

AMIODARONE; DEFEROXAMINE; THYROID ANTIBODY; THYROID HORMONE; THYROTROPIN; THYROXINE;

ADULT; ARTICLE; BETA THALASSEMIA; CARDIOMYOPATHY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; MALE; THALASSEMIA MAJOR; THYROID DISEASE; THYROID HORMONE BLOOD LEVEL; THYROTOXICOSIS; TIME;

EID: 0032969047     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03345479     Document Type: Article

References (45)

1. Gill J., Heel R.C., Fitton A. Amiodarone. An overview of its pharmacological properties, and review of its therapeutic use in cardiac arrhythmias. Drugs 43: 69, 1992.
2. Burger A., Dinichert D., Nicod P., Jenny M., Lemarchand-Beraud T., Vallotton M.B. Effect of amiodarone on serum triiodothyronine, reverse triiodothyronine, thyroxine and thyrotropin. A drug influencing peripheral metabolism of thyroid hormone. J. Clin. Invest. 58: 255, 1976.
3. Sing B.N., Nademanee K. Amiodarone and thyroid function: clinical implications during antiarrhythmic therapy. Am. Heart J. 106: 857, 1983.
4. Martino E., Safran M., Aghini-Lombardi F., Rajatanavin R., Lenziardi M., Fay M., Pacchiarotti A., Aronin N., Macchia E., Haffajee C., Odoguardi L., Love J., Bigalli A., Baschieri L., Pinchera A., Braverman L.E. Environmental iodine intake and thyroid dysfunction during chronic amiodarone therapy. Ann. Intern. Med. 101: 28, 1984.
5. Martino E., Aghini L.F., Mariotti S., Bartalena L., Braverman L., Pinchera A. Amiodarone: a common source of iodine-induced thyrotoxicosis. Horm. Res. 26: 158, 1987.
6. Martino E., Aghini-Lombardi F., Mariotti S., Bartalena L., Lenziardi M., Ceccarelli C., Bambini G., Safran M., Braverman L.E. Amiodarone iodine-induced hypothyroidism: risk factors and follow-up in 28 cases. Clin. Endocrinol. (Oxf.) 26: 227, 1987.
7. Figge H.L., Figge J. The effects of amiodarone on thyroid hormone function: a review of the physiology and clinical manifestations. J. Clin. Pharmacol. 30: 588, 1990.
8. Trip M.D., Wiersinga W., Plomp T.A. Incidence, predictability, and pathogenesis of amiodarone-induced thyrotoxicosis and hypothyroidism. Am. J. Med. 91: 507, 1991.
9. Martino E., Aghini-Lombardi F., Bartalena L., Grasso L., Loviselli A., Velluzzi F., Pinchera A., Braverman L.E. Enhanced susceptibility to amiodarone-induced hypothyroidism in patients with thyroid autoimmune disease. Arch. Intern. Med. 154: 2722, 1994.
10. Harjai K.J., Licata A.A. Effects of amiodarone on thyroid function. Ann. Intern. Med. 126: 63, 1997.
11. Martino E., Aghini-Lombardi F., Mariotti S., Lenziardi M., Baschieri L., Braverman M.E., Pinchera A. Treatment of amiodarone associated thyrotoxicosis by simultaneous administration of potassium perchlorate and methimazole. J. Endocrinol. Invest. 9: 201, 1986.
12. Aghini-Lombardi F., Mariotti S., Fosella P.V., Grasso L., Pinchera A., Braverman L.E., Martino E. Treatment of amiodarone iodine-induced thyrotoxicosis with plasmapheresis and methimazole. J. Endocrinol. Invest. 16: 823, 1993.
13. Safran M., Martino E., Aghini-Lombardi F., Bartalena L., Balzano S., Pinchera A., Braverman L.E. Effect of amiodarone on circulating antithyroid antibodies. Br. Med. J. 297: 456, 1988.
14. Hauser S.C. Hemochromatosis and the heart. Heart Dis. Stroke 2: 487, 1993.
15. Liu P., Olivieri N. Iron overload cardiomyopathies: new insights into an old disease. Cardiovasc. Drugs Ther. 8: 101, 1994.
16. Sabato A.R., De Sanctis V., Atti G., Capra L., Bagni B., Vullo C. Primary hypothyroidism and the low T3 syndrome in thalassemia major. Arch. Dis. Child. 58: 120, 1983.
17. Cavallo L., Licci D., Acquafredda A., Marranzini M., Beccasio R., Scardino M.L., Altomare M., Mastro F., Sisto L., Schettini F. Endocrine involvement in children with beta-thalassaemia major. Transverse and longitudinal studies. I. Pituitary-thyroidal axis function and its correlation with serum ferritin levels. Acta Endocrinol. (Copenh.) 107: 49, 1984.
18. Masala A., Meloni T., Gallisai D., Alagna S., Rovasio P.P., Rassu S., Milia A.F. Endocrine functioning in multi-transfused prepupertal patients with homozygous beta-thalassemia. J. Clin. Endocrinol. Metab. 58: 667, 1984.
19. De Sanctis V., Vullo C., Katz M., Wonke B., Hoffbrand A.V., Bagni B. Hypothalamic-pituitary-gonadal axis in thalassemic patients with secondary amenorrhea. Obstet. Gynecol. 72: 643, 1988.
20. Magro S., Puzzonia P., Consarino C., Galati M.C., Morgione S., Porcelli D., Grimaldi S., Tancre D., Arcuri V., De Sanctis V., et al. Hypothyroidism in patients with thalassemia syndromes. Acta Haematol. 84: 72, 1990.
21. Agarwal M.B., Shah S., Vishwanathan C., Rajadhyaksha G., Bhave A.A., Dube S.R., Billa V., Malkan G., Bajan K. Thyroid dysfunction in multi-transfused iron loaded thalassemia patients. Indian Pediatr. 29: 997, 1992.
22. Danesi L., Scacchi M., De Martin M., Dubini A., Massaro P., Majolo A.T., Cavagnini F., Polli E.E. Evaluation of hypothalamic-pituitary function in patients with thalassemia major. J. Endocrinol. Invest. 15: 177, 1992.
23. Landau H., Matoth I., Landau C.Z., Goldfarb A., Rachmilewitz E.A., Glaser B. Cross-sectional and longitudinal study of the pituitary-thyroid axis in patients with thalassaemia major. Clin. Endocrinol. (Oxf.) 38: 55, 1993.
24. Pantelakis S. Thyroid disorders and diabetes mellitus as complications of thalassaemia major. Acta Paediatr. (Suppl.) 406: 111, 1994.
25. De Sanctis V., Pintor C., Gamberini M.R., Ughi M., Pinamonti A., Aliquo M.C., Anastasi S., Andò S., Brancati C., Bruno M.A., et al. Multicentre study on prevalence of endocrine complications in thalassaemia major: Italian working group on endocnne complications in non-endocrine diseases. Clin. Endocrinol. (Oxf.) 42: 581, 1995.
26. De Simone M., Olioso P., Di Bartolomeo P., Di Girolamo G., Farello G., Palumbo M., Papalinetti G., Bavaro P., Angrilli F., Torlontano G., et al. Growth and endocrine function following bone marrow transplantation for thalassemia. Bone Marrow Transplant. 15: 227, 1995.
27. Papadimas J., Mandala E., Pados G., Kokkas B., Georgiadis G., Tarlatzis B., Bontis J., Sinakos Z., Mantalenakis S. Pituitary-testicular axis in men with beta-thalassaemia major. Hum. Reprod. 11: 1900, 1996.
28. Phanekos C., Kamerou A., Pipis P., Constantoulakis M., Lasaridis J., Detsi S., Politou K. Thyroid function in patients with homozygous β-thalassaemia. Clin. Endocrinol. (Oxf.) 20: 445, 1984.
29. Martino E., Loviselli A., Velluzzi F., Murtas M.L., Carta M., Lampis M., Murru R., Mastinu A., Arba M.L., Sica V., Taberlet A., Grasso L., Maccherini D., Antonangeli L., Aghini-Lombardi F. Endemic goiter and thyroid function in Central-Southern Sardinia: Report on an extensive epidemiological survey. J. Endocrinol. Invest. 17: 653, 1994.
30. Roti E., Minelli R., Gardini E., Bianconi L., Braverman L.E. Thyrotoxicosis followed by hypothyroidism in patients treated with amiodarone. A possible consequence of a destructive process in the thyroid. Arch. Intern. Med. 153: 886, 1993.
31. Brennan M.D., Erickson D.Z., Carney J.A., Bahn R.S. Nongoitrous (Type I) amiodarone-associated thyrotoxicosis: Evidence of follicular disruption in vitro and in vivo. Thyroid 5: 177, 1995.
32. Braverman L.E., Woeber K.A., Ingbar S.H. Induction of myxedema by iodide in patients euthyroid after radioiodine or surgical treatment of diffuse toxic goiter. N. Engl. J. Med. 281: 816, 1969.
33. Braverman L.E., Ingbar S.H., Vagenakis A.G., Adams L., Maloof F. Enhanced susceptibility to iodide myxedema in patients with Hashimoto's disease. J. Clin. Endocrinol. Metab. 32: 515, 1971.
34. Braverman L.E. Iodine induced thyroid disease. Acta Med. Austriaca 1: 29, 1990.
35. Roti E., Minelli R., Gardini E., Bianconi L., Neri T., Gavaruzzi G., Ugolotti G., Salvo D., Braverman L.E. Impaired intrathyroidal iodine organification and iodine-induced hypothyroidism in euthyroid women with a previous episode of postpartum thyroiditis. J. Clin. Endocrinol. Metab. 73: 958, 1991.
36. Minelli R., Gardini E., Bianconi L., Salvi M., Roti E. Subclinical hypothyroidism, overt thyrotoxicosis and subclinical hypothyroidism. The subsequent phases of thyroid function in a patient chronically treated with amiodarone. J. Endocrinol. Invest. 15: 853, 1992.
37. th Annual Meeting of the Endocrine Society: 215, 1995.
38. Safran M., Paul T.L., Roti E., Braverman L.E. Environmental factors affecting autoimmune thyroid disease. Endocrinol. Metab. North Am. 16: 327, 1987.
39. Loviselli A., Bartalena L., Balzano S., Aghini L.F., Sica V., Pilosu R., Petrini L., Giannessi G., Buratti L., Martino E. Absence of serum thyroid hormone autoantibodies in patients chronically treated with amiodarone. J. Endocrinol. Invest. 11: 323, 1988.
40. Brown T.R., Bagchi N. The role of iodine in the development of autoimmune thyroiditis. Int. Rev. Immunol. 9: 167, 1992.
41. Sundick R.S., Bagchi N., Brown T.R. The role of iodine in thyroid autoimmunity: from chickens to humans: a review. Autoimmunity 13: 61, 1992.
42. Bartalena L., Grasso L., Brogioni S., Aghini-Lombardi F., Braverman I.E., Martino E. Serum interleukin-6 in amiodarone-induced thyrotoxicosis. J. Clin. Endocrinol. Metab. 78: 423, 1994.
43. Fradkin J.E., Wolff J. Iodide-induced thyrotoxicosis. Medicine (Baltimore) 62: 1, 1983.
44. Klein I. Thyroid hormone and the cardiovascular system. Am. J. Med. 88: 631, 1990.
45. Ladenson P.W. Editorial: thyrotoxicosis and the heart: something old and something new. J. Clin. Endocrinol. Metab. 77: 332, 1993.